FDL169抑制劑FDL-169 is a novel and potent CFTR (Cystic fibrosis transmembrane conductance regulator) corrector for treating cystic fibrosis (CF) patients who carry the F508del mutation.
| 產(chǎn)品名稱： | FDL169 | ||
| 英文名： | FDL169 | ||
| CAS NO.： | 1628416-28-3 | ||
| 分子式： | |||
| 分子量： | |||
| 產(chǎn)品品牌： | targetmol | ||
| 產(chǎn)品規(guī)格： | 2 mg | ||
